エーザイ、レカネマブがグローバル大規模臨床第III相CLARITY AD検証試験で統計学的に高度に有意な臨床症状の悪化抑制を示し、主要評価項目を達成 Eisai Sep 28, 2022 09:00 JST Read More
Eisai: Metoject Subcutaneous Injection Syringe (Methotrexate) Approved in Japan for Rheumatoid Arthritis Eisai Sep 26, 2022 19:14 HKT/SGT Read More
エーザイ:「メトジェクト(R) 皮下注シリンジ」(一般名:メトトレキサート)が日本において関節リウマチに係る製造販売承認を取得 Eisai Sep 26, 2022 15:00 JST Read More
AIM Vaccine Announces Proposed Listing on the Main Board of SEHK AIM Vaccine Co., Ltd. Sep 23, 2022 17:06 HKT/SGT Read More
Malaysian Genomics Grows Presence in Thailand Malaysian Genomics Resource Centre Bhd Sep 23, 2022 15:00 JST Read More
Malaysian Genomics Grows Presence in Thailand Malaysian Genomics Resource Centre Bhd Sep 23, 2022 14:00 HKT/SGT Read More
深睿医疗联合华西医院最新研究被 NPJ-Digital Medicine收录,全面提高肺部疾病诊断效率和准确性 Deep Wise Sep 22, 2022 18:00 HKT/SGT Read More
深睿醫療聯合華西醫院最新研究被 NPJ-Digital Medicine收錄,全面提高肺部疾病診斷效率和準確性 Deep Wise Sep 22, 2022 18:00 HKT/SGT Read More
Agilis Robotics Targeting its Pre-B Round Fund-raising to be Completed by 2022 Agilis Robotics Limited Sep 22, 2022 14:13 HKT/SGT Read More
Malaysian Genomics, Rinani Genotec Sign LOI with Universiti Malaysia Sabah Malaysian Genomics Resource Centre Bhd Sep 21, 2022 19:00 HKT/SGT Read More
노보텍,제6회CGTWA 컨퍼런스에서‘2022세포유전자치료제우수상’수상 Novotech Health Holdings Pte Ltd Sep 17, 2022 07:00 HKT/SGT Read More
Novotech 在第六屆細胞與基因治療世界亞洲會議上榮獲 2022 年細胞與基因卓越獎 Novotech Health Holdings Pte Ltd Sep 16, 2022 10:00 HKT/SGT Read More
Novotech 在第六届细胞与基因治疗世界亚洲会议上荣获 2022 年细胞与基因卓越奖 Novotech Health Holdings Pte Ltd Sep 16, 2022 10:00 HKT/SGT Read More
Novotech presented with Cell & Gene Excellence Award 2022 at 6th Cell & Gene Therapy World Asia Conference Novotech Health Holdings Pte Ltd Sep 15, 2022 17:00 HKT/SGT Read More
Indonesia's Bio Farma ready to produce IndoVac Covid-19 vaccines PT Bio Farma (Persero) Sep 13, 2022 06:40 HKT/SGT Read More
Eisai and Merck & Co., Inc. Present Results from Phase 3 LEAP-002 Trial Evaluating LENVIMA (lenvatinib) Plus KEYTRUDA (pembrolizumab) Versus LENVIMA Monotherapy in Patients With Unresectable Hepatocellular Carcinoma Eisai Sep 12, 2022 14:37 HKT/SGT Read More
エーザイと Merck、切除不能な肝細胞がんを対象として「レンビマ」と「キイトルーダ」との併用療法と「レンビマ」単剤療法を比較評価した臨床第III相 LEAP-002 試験の結果を発表 Eisai Sep 12, 2022 09:00 JST Read More